Related Experiment Video
Updated: May 31, 2026

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
"MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trial
Amber E Ten Hoedt1, Carla Em Hollak, Carolien Ca Boelen
1Department of Pediatrics, Academic Medical Center (AMC), University of Amsterdam, AZ Amsterdam, The Netherlands. a.m.bosch@amc.uva.nl
Insights
Phenylketonuria (PKU) patients can safely manage their condition with increased self-care. Providing online access to phenylalanine (Phe) levels empowers patients and parents, showing high satisfaction with this approach.
Area of Science:
- Metabolic Disorders
- Genetics
- Pediatrics
Background:
- Phenylketonuria (PKU) is an inherited metabolic disorder requiring strict dietary management to prevent cognitive impairment.
- Elevated phenylalanine (Phe) levels result from impaired metabolism and necessitate lifelong adherence to a low-protein diet.
- Current PKU management relies on regular monitoring of plasma Phe levels and dietary adjustments.
Purpose of the Study:
- To evaluate the feasibility and safety of enhanced patient self-management in PKU.
- To assess the impact of providing direct online access to blood phenylalanine (Phe) values without immediate professional guidance.
Main Methods:
- A 10-month randomized controlled trial involving 38 PKU patients (age ≥ 1 year).
- The study group received online access to Phe values via a "My PKU" web page, while the control group followed standard dietician communication.
- Outcome measures included changes in mean Phe levels, percentage of values above the recommended range, and sampling frequency.
Main Results:
- No significant differences were observed in mean Phe levels, percentage of elevated values, or blood sampling frequency between the study and control groups.
- All participants reported high satisfaction with the online self-management system.
Conclusions:
- Increased self-management through online Phe value access is feasible and safe for PKU patients and their parents.
- This approach is highly appreciated by patients and families, suggesting a valuable tool for PKU care.
Background:
Phenylketonuria (PKU) is an autosomal recessive disorder of phenylalanine metabolism. The inability to convert phenylalanine (Phe) into tyrosine causes Phe to accumulate in the body. Adherence to a protein restricted diet, resulting in reduced Phe levels, is essential to prevent cognitive decline. Frequent evaluation of plasma Phe levels and, if necessary, adjustment of the diet are the mainstay of treatment. We aimed to assess whether increased self-management of PKU patients and/or their parents is feasible and safe, by providing direct online access to blood Phe values without immediate professional guidance.
Methods:
Thirty-eight patients aged ≥ 1 year participated in a 10 month randomized controlled trial. Patients were randomized into a study group (1) or a control group (2). Group 2 continued the usual procedure: a phone call or e-mail by a dietician in case of a deviant Phe value. Group 1 was given a personal "My PKU" web page with a graph of their recent and previous Phe values, online general information about the dietary treatment and the Dutch PKU follow-up guidelines, and a message-box to contact their dietician if necessary. Phe values were provided on "My PKU" without advice. Outcome measures were: differences in mean Phe value, percentage of values above the recommended range and Phe sample frequency, between a 10-month pre-study period and the study period in each group, and between the groups in both periods. Furthermore we assessed satisfaction of patients and/or parents with the 'My PKU' procedure of online availability.
Results:
There were no significant differences in mean Phe value, percentage of values above recommended range or in frequency of blood spot sampling for Phe determination between the pre-study period and the study period in each group, nor between the 2 groups during the periods. All patients and/or parents expressed a high level of satisfaction with the new way of disease management.
Conclusions:
Increased self-management in PKU by providing patients and/or parents their Phe values without advice is feasible and safe and is highly appreciated.
Trial Registration:
The trial was registered with The Netherlands National Trial Register (NTR #1171) before recruitment of patients.
Related Concept Videos
Inborn Errors of Metabolism
Chronic Kidney Disease III: Interprofessional Care
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Peritoneal Dialysis III: Nursing Management
Chronic Kidney Disease IV: Nursing Management
Bioavailability Study Design: Healthy Subjects Versus Patients